Valeant to acquire Salix in $14.5 billion deal

dimanche 22 février 2015

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec Valeant Pharmaceuticals International Inc. agreed to acquire Salix Pharmaceuticals Ltd. for $158.00 per share, or a total enterprise value of $14.5 billion, the two companies said on Sunday. The transaction, ...








via Business News http://ift.tt/1D0lWLL

0 commentaires:

Enregistrer un commentaire